Michelle L Hastings

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

High Fat Diet Induced

Combination Therapy

Protein Protein

Top Venues

RNA (New York, N.Y.)

The EMBO journal

Nature medicine

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Rosalind Franklin University of Medicine and Science

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Rosalind Franklin University of Medicine and Science

United States

Professor :: Chicago Medical School/Center for Genetic Disease

Publications

Mallory A Havens, Anthony J Hinrich, Frank Rigo, Michelle L Hastings
Increasing MicroRNA Abundance by Targeting Biogenesis from the Primary Transcript with Steric-Blocking Antisense Oligonucleotides. RNA (New York, N.Y.) (2024)
Roni Klein, Janset Onyuru, Estela M Viera, Christopher D Putnam, Hal M Hoffman, Michelle L Hastings
Modulating NLRP3 splicing with antisense oligonucleotides to control pathological inflammation. bioRxiv : the preprint server for biology (2024)
Michelle L Hastings, Adrian R Krainer
RNA therapeutics. RNA (New York, N.Y.) 29 (4) (2023)
Konstadinos Moissoglu, Michael Stueland, Alexander N Gasparski, Tianhong Wang, Lisa M Jenkins, Michelle L Hastings, Stavroula Mili
RNA localization and co-translational interactions control RAB13 GTPase function and cell migration. The EMBO journal 39 (21) (2020)
Michelle L Hastings, Timothy A Jones
Antisense Oligonucleotides for the Treatment of Inner Ear Dysfunction. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 16 (2) (2020)
Jessica L Centa, Francine M Jodelka, Anthony J Hinrich, Tyler B Johnson, Joseph Ochaba, Michaela Jackson, Dominik M Duelli, Jill M Weimer, Frank Rigo, Michelle L Hastings
Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten disease. Nature medicine 26 (9) (2020)